123I-MNI-308

N/A

Report date: 2025/12/01 17:52:07
NME

Base Information

Drug Name123I-MNI-308
Drug Alias Name123I-MNI-308
ClassificationSmall moleculesDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsDiagnostic agentsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Neuroimaging Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Neuroimaging Llc
Active IndicationsN/A
Inactive IndicationsDiagnostic agentsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A